Category Archives: Press Release

Press Release Quote
BioReference Laboratories Showcases 2019 Growth through the Addition of Cutting Edge Tests, Greater Access to Services, and Optimized Patient Experience

ELMWOOD PARK, N.J., December 19, 2019 – BioReference Laboratories, Inc., an OPKO Health Company, along [...]

19
Dec
BioReference Laboratories Selected as Preferred Laboratory Provider by The IPA Association Of America

BioReference to Provide Diagnostic Test Services and Assist with Patient-Centered Data Analytics ELMWOOD PARK, NJ. [...]

01
Aug
BioReference Laboratories Forms a Strategic Collaboration with SOMOS to Improve Health Outcomes of Underserved New Yorkers

BioReference to also assist with Patient-Centered Data Analytics to SOMOS Providers SOMOS, New York City’s [...]

01
Jul
BioReference Laboratories Supports Man Cave Health During National Men’s Health Month

Complimentary PSA Testing Provided to Participants of Annual Golf Tournament ELMWOOD PARK, N.J., June 7 – [...]

07
Jun
Aerobic Vaginitis (AV) Testing Now Available At BioReference Laboratories

BioReference Laboratories, Inc., along with its specialty women’s health division, GenPath, today announces the launch [...]

17
May
OPKO Health Appoints Jon R. Cohen, M.D. Executive Chairman of BioReference Laboratories
January 7, 2019

Geoff Monk promoted to President   MIAMI, Jan. 07, 2019 – OPKO Health, Inc. (NASDAQ: OPK) today announced the [...]

BioReference Laboratories Named as Preferred Laboratory with Horizon Healthcare Services Serving Members of Horizon Healthcare Services, Inc.
November 8, 2018

MIAMI, FL NOVEMBER 8, 2018 — BioReference Laboratories, Inc. (BRL), an OPKO Health company and the third largest clinical laboratory [...]

OPKO Plans to Address Draft Local Coverage Determination Published by Novitas Solutions for 4Kscore Test
May 18, 2018

MIAMI, May 18, 2018 (GLOBE NEWSWIRE) — OPKO Health, Inc.(Nasdaq:OPK) today announced that Novitas Solutions, Inc. issued a draft local [...]

OPKO Health Appoints Geoff Monk General Manager at BioReference Laboratories
May 1, 2018

MIAMI, May 01, 2018 (GLOBE NEWSWIRE) — OPKO Health, Inc.(NASDAQ:OPK) today announced the appointment of Geoff Monkas General Manager [...]

OPKO Health Announces Landmark Study Showing 4Kscore® Test is Strong Predictor of Prostate Cancer Mortality Published in European Urology
March 16, 2018

Study of 11,506 men shows that healthy men with an abnormal PSA and a low 4Kscore test result can [...]